Dr. Haque is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuroradiology, 2002 - 2003
- Maimonides Medical CenterResidency, Radiology-Diagnostic, 2000 - 2002
- University of Virginia Medical CenterResidency, Radiology-Diagnostic, 1998 - 2000
- Emory University School of MedicineInternship, Transitional Year, 1997 - 1998
- Emory University School of MedicineClass of 1997
Certifications & Licensure
- NY State Medical License 2002 - 2026
- NJ State Medical License 2006 - 2025
- GA State Medical License 1999 - 2005
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
Clinical Trials
- Neurocutaneous Melanocytosis Registry Start of enrollment: 2020 Sep 03
Roles: Contact
Publications & Presentations
PubMed
- Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG).Mark M Souweidane, Evan D Bander, Pat Zanzonico, Anne S Reiner, Nicole Manino
Neuro-Oncology. 2025-02-19 - Neurocutaneous Melanocytosis-Associated Hydrocephalus: The Memorial Sloan Kettering Experience from 2001 to 2022.Scarlett Rodriguez, Francesca DeIeso-Frechette, Chidobe Umeasor, Christianah Alli, Caline Azzi
Pediatric Blood & Cancer. 2025-01-01 - 1 citationsEvolutionary Strategies AI Addresses Multiple Technical Challenges in Deep Learning Deployment: Proof-of-Principle Demonstration for Neuroblastoma Brain Metastasis Det...Subhanik Purkayastha, Hrithwik Shalu, David Gutman, Andrei Holodny, Shakeel Modak
Journal of Imaging Informatics in Medicine. 2024-12-01
Journal Articles
- Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersSteven M Larson, Sofia Haque, Duan Li, R Michael Tuttle, Mona M Sabra, Alan L Ho, Eric J Sherman, Ravinder K Grewal, James A Fagin, David G Pfister, Ronald A Ghossein, The Journal of Clinical Endocrinology and Metabolism
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: